ATE208201T1 - Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin - Google Patents

Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin

Info

Publication number: ATE208201T1
Authority: AT; Austria
Prior art keywords: tiazofurin; ribavirin; imp; remission; administered
Prior art date: 1993-05-18

Application number

AT94916011T

Other languages

English (en)

Inventor

George Weber

Original Assignee

Advanced Res & Tech Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-18

Filing date

1994-05-05

Publication date

2001-11-15

1994-05-05 Application filed by Advanced Res & Tech Inst filed Critical Advanced Res & Tech Inst

2001-11-15 Application granted granted Critical

2001-11-15 Publication of ATE208201T1 publication Critical patent/ATE208201T1/de

Links

FVRDYQYEVDDKCR-DBRKOABJSA-N tiazofurine Chemical compound NC(=O)C1=CSC([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)=N1 FVRDYQYEVDDKCR-DBRKOABJSA-N 0.000 title abstract 5
229960003723 tiazofurine Drugs 0.000 title abstract 5
IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title abstract 3
229960000329 ribavirin Drugs 0.000 title abstract 3
HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title abstract 3
201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
230000001613 neoplastic effect Effects 0.000 title abstract 2
230000000694 effects Effects 0.000 abstract 2
230000002489 hematologic effect Effects 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
230000009286 beneficial effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT94916011T 1993-05-18 1994-05-05 Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin ATE208201T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/065,348 US5405837A (en)	1993-05-18	1993-05-18	Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
PCT/US1994/004952 WO1994026281A1 (en)	1993-05-18	1994-05-05	Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin

Publications (1)

Publication Number	Publication Date
ATE208201T1 true ATE208201T1 (de)	2001-11-15

Family

ID=22062092

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94916011T ATE208201T1 (de)	1993-05-18	1994-05-05	Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin

Country Status (13)

Country	Link
US (1)	US5405837A (de)
EP (1)	EP0707479B1 (de)
JP (1)	JP2951407B2 (de)
KR (1)	KR100310121B1 (de)
AT (1)	ATE208201T1 (de)
AU (1)	AU679531B2 (de)
BR (1)	BR9406534A (de)
CA (1)	CA2161970C (de)
DE (1)	DE69428995T2 (de)
ES (1)	ES2164703T3 (de)
NZ (1)	NZ266359A (de)
RU (1)	RU2149004C1 (de)
WO (1)	WO1994026281A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9307043D0 (en) *	1993-04-05	1993-05-26	Norsk Hydro As	Chemical compounds
CN1334736A (zh) *	1999-01-29	2002-02-06	Icn药品公司	病毒唑对免疫反应的调节作用
US6455508B1 (en) *	2000-02-15	2002-09-24	Kanda S. Ramasamy	Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
US6720000B2 (en) *	2001-03-19	2004-04-13	Three Rivers Pharmaceutical, Llc	Process for producing wet ribavirin pellets
HUP0402364A2 (hu) *	2001-11-02	2005-02-28	Sandoz Ag	Gyorsan oldódó, nagy koncentrációjú ribavirinkészítmények
WO2004012746A2 (en) *	2002-08-02	2004-02-12	The Regents Of The University Of California	New uses for inhibitors of inosine monophosphate dehydrogenase
US7538094B2 (en) *	2002-09-19	2009-05-26	Three Rivers Pharmacueticals, Llc	Composition containing ribavirin and use thereof
EP2803357B1 (de)	2004-06-25	2020-11-18	The Johns-Hopkins University	Angiogenesehemmer
US8497292B2 (en)	2005-12-28	2013-07-30	Translational Therapeutics, Inc.	Translational dysfunction based therapeutics
KR101162710B1 (ko) *	2009-01-23	2012-07-05	(주) 비엔씨바이오팜	도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물
WO2020123241A1 (en) *	2018-12-10	2020-06-18	Clear Creek Bio, Inc.	Multiphasic dosing regimens for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4211771A (en) *	1971-06-01	1980-07-08	Robins Ronald K	Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US4680285A (en) *	1980-12-15	1987-07-14	Viratek, Inc.	Treatment of malignant tumors with 2-(β-D-ribofuranosylthiazole-4-carboxamide related compounds
GB8800276D0 (en) *	1988-01-07	1988-02-10	Univ Liverpool	Medical treatment

1993
- 1993-05-18 US US08/065,348 patent/US5405837A/en not_active Expired - Fee Related
1994
- 1994-05-05 BR BR9406534A patent/BR9406534A/pt not_active Application Discontinuation
- 1994-05-05 AT AT94916011T patent/ATE208201T1/de not_active IP Right Cessation
- 1994-05-05 RU RU95122466A patent/RU2149004C1/ru not_active IP Right Cessation
- 1994-05-05 NZ NZ266359A patent/NZ266359A/en unknown
- 1994-05-05 CA CA002161970A patent/CA2161970C/en not_active Expired - Fee Related
- 1994-05-05 AU AU67827/94A patent/AU679531B2/en not_active Ceased
- 1994-05-05 ES ES94916011T patent/ES2164703T3/es not_active Expired - Lifetime
- 1994-05-05 JP JP6525531A patent/JP2951407B2/ja not_active Expired - Fee Related
- 1994-05-05 KR KR1019950705126A patent/KR100310121B1/ko not_active Expired - Fee Related
- 1994-05-05 WO PCT/US1994/004952 patent/WO1994026281A1/en not_active Ceased
- 1994-05-05 EP EP94916011A patent/EP0707479B1/de not_active Expired - Lifetime
- 1994-05-05 DE DE69428995T patent/DE69428995T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR100310121B1 (ko)	2001-12-28
CA2161970C (en)	2005-06-21
KR960702313A (ko)	1996-04-27
US5405837A (en)	1995-04-11
JP2951407B2 (ja)	1999-09-20
EP0707479B1 (de)	2001-11-07
EP0707479A1 (de)	1996-04-24
NZ266359A (en)	1997-07-27
RU2149004C1 (ru)	2000-05-20
EP0707479A4 (de)	1998-04-15
DE69428995D1 (de)	2001-12-13
HK1011614A1 (en)	1999-07-16
WO1994026281A1 (en)	1994-11-24
DE69428995T2 (de)	2002-06-06
ES2164703T3 (es)	2002-03-01
CA2161970A1 (en)	1994-11-24
AU6782794A (en)	1994-12-12
JPH08510450A (ja)	1996-11-05
BR9406534A (pt)	1996-01-02
AU679531B2 (en)	1997-07-03

Similar Documents

Publication	Publication Date	Title
ATE185268T1 (de)	1999-10-15	Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE69132688D1 (de)	2001-09-20	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69914084D1 (de)	2004-02-12	Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
ATE114118T1 (de)	1994-12-15	System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren.
DE69930739D1 (de)	2006-05-18	Transdermale verwendung von sekretin zur behandlung von autismus
DE69332624D1 (de)	2003-02-13	WUNDHEILMITTEL UND BEHANDLUNG VON FIBROTISCHEN STORUNGEN DURCH TGFbeta-3
DE69012591D1 (de)	1994-10-27	Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
ATE348808T1 (de)	2007-01-15	Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
ATE93138T1 (de)	1993-09-15	Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE69428995D1 (de)	2001-12-13	Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin
ATE209920T1 (de)	2001-12-15	Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
ATE375149T1 (de)	2007-10-15	Behandlung von entzug
HU213677B (en)	1997-12-29	Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
DE69424777D1 (de)	2000-07-06	3,4-diarylchromane zur behandlung von dermatitis
ATE77751T1 (de)	1992-07-15	Mittel zur behandlung von knochenkrankheiten.
ATE44156T1 (de)	1989-07-15	Kovalent gebundener heparin-antithrombin iiikomplex, verfahren zu dessen herstellung und seine verwendung zur behandlung von thrombusembolie.
ATE184484T1 (de)	1999-10-15	Wirkstoffe zur behandlung von suchterkrankungen
ATE281841T1 (de)	2004-11-15	Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
EP1056458A4 (de)	2001-06-20	Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
ATE499946T1 (de)	2011-03-15	Verwendung von hgf für die behandlung von ischämischen erkrankungen der extremitäten
ATE295731T1 (de)	2005-06-15	Olanzapine zur behandlung von drogenmissbrauch
RU94045317A (ru)	1996-10-27	Способ лечения вилюйского энцефаломиелита
RU96124055A (ru)	1999-02-27	Способ лечения эпилепсии у детей
RU94003799A (ru)	1995-12-10	Способ лечения псороптозов животных
RU96122371A (ru)	1998-09-10	Способ лечения эндогенных и послеоперационных увеитов

Legal Events

Date	Code	Title
2002-04-15	UEP	Publication of translation of european patent specification
2005-11-15	EEFA	Change of the company name
2007-02-15	REN	Ceased due to non-payment of the annual fee